Insights On Outsourced Drug Development

  1. Considerations In Design And Development Of Novel Combination Drug-Delivery Devices 7/17/2026

    Poor scoping kills drug delivery device programs before they start. Learn how to define the right problem, assess risk early, and set boundaries that protect your timeline and budget.

  2. Ask Us Anything: Miles Blackburn On Advances In Flow And Radical Chemistry 7/23/2026

    Miles Blackburn, Associate Director of Chemistry at Snapdragon Chemistry, on why the biggest payoff of flow and radical chemistry is speed — processes that scale fast enough to get intermediates and APIs delivered on a clinical timeline.

  3. Patented Process For Intermediates Useful For Etrasimod Arginine 3/13/2026

    Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.

  4. Denaturing SEC-MS Analysis Of High Molecular Weight Impurities 3/18/2026

    Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity.

  5. Increase Throughput For Intact Mass Confirmation And Impurity Screening 8/24/2026

    Accelerate intact mass analysis of GLP-1 analogues with automated purity calculations, sub-ppm mass accuracy, and impurity detection for consistent results in under one minute per sample.

  6. 3 Key Considerations In Gene Therapy Manufacturing 7/15/2025

    Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.

  7. API In Capsule Vs. The Lost Art Of Formulation Development 11/5/2025

    API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.

  8. Patented Process For Intermediates Useful For Deucravacitinib 3/13/2026

    Discover how this patented synthetic approach to Deucravacitinib intermediates can improve yield, simplify purification, and support scalable, regulatory-aligned manufacturing.

  9. Bioanalytical Quantification Of A Biotherapeutic Peptide 7/17/2025

    Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.

  10. Grace Capabilities Update February 2026: AI Drug Development 3/2/2026

    Discover support for your next small molecule drug substance program and learn how artificial intelligence and machine learning tools can be applied to accelerate API development.